Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30054123HIVENSG00000101204.18protein_codingCHRNA4NoNo1137P43681
Q4VAQ3
TVIS20067223HPVENSG00000101204.18protein_codingCHRNA4NoNo1137P43681
Q4VAQ3
TVIS20037058HPVENSG00000101204.18protein_codingCHRNA4NoNo1137P43681
Q4VAQ3
TCGA Plot Options
Drug Information
GeneCHRNA4
DrugBank IDDB01273
Drug NameVarenicline
Target IDBE0000849
UniProt IDP43681
Regulation Typepartial agonist
PubMed IDs17692720; 18288085; 17573127; 17626178; 11752352
CitationsNakamura M, Oshima A, Fujimoto Y, Maruyama N, Ishibashi T, Reeves KR: Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers. Clin Ther. 2007 Jun;29(6):1040-56.@@McColl SL, Burstein AH, Reeves KR, Billing CB Jr, Stolar M, Sellers EM: Human abuse liability of the smoking cessation drug varenicline in smokers and nonsmokers. Clin Pharmacol Ther. 2008 Apr;83(4):607-14. doi: 10.1038/sj.clpt.6100510. Epub 2008 Feb 20.@@Rollema H, Coe JW, Chambers LK, Hurst RS, Stahl SM, Williams KE: Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation. Trends Pharmacol Sci. 2007 Jul;28(7):316-25. Epub 2007 Jun 18.@@Steensland P, Simms JA, Holgate J, Richards JK, Bartlett SE: Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking. Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12518-23. Epub 2007 Jul 11.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.
GroupsApproved; Investigational
Direct Classification
SMILESC1C2CNCC1C1=C2C=C2N=CC=NC2=C1
Pathways
PharmGKBPA164781343
ChEMBLCHEMBL1396